Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership |
2021-08-09 6:20 pm |
N/A N/A |
Eliem Therapeutics Inc. | ELYM | Rosenberg Adam Joseph Director |
0 | $0 | 178,100 (Direct) |
View |
Ownership |
2021-08-09 6:18 pm |
N/A N/A |
Eliem Therapeutics Inc. | ELYM | Tate Simon Director |
0 | $0 | 0 (Direct) |
View |
Ownership |
2021-08-09 6:16 pm |
N/A N/A |
Eliem Therapeutics Inc. | ELYM | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
0 | $0 | 9,950,849 (Indirect) |
View |
Ownership |
2021-08-09 6:16 pm |
N/A N/A |
Eliem Therapeutics Inc. | ELYM | Levin Andrew David Director |
0 | $0 | 0 (Direct) |
View |
Ownership |
2021-08-09 6:13 pm |
N/A 2031-02-25 |
Eliem Therapeutics Inc. | ELYM | Bucher James B EVP and General Counsel |
0 | $0 | 198,410 (Direct) |
View |
Ownership |
2021-08-09 6:11 pm |
N/A 2031-02-25 |
Eliem Therapeutics Inc. | ELYM | Lavelle Erin COO & CFO |
0 | $0 | 357,138 (Direct) |
View |
Ownership |
2021-08-09 6:08 pm |
N/A N/A |
Eliem Therapeutics Inc. | ELYM | Morisset Valerie Chief Scientific Officer |
0 | $0 | 533,353 (Direct) |
View |
Ownership |
2021-08-09 6:02 pm |
N/A 2031-02-25 |
Eliem Therapeutics Inc. | ELYM | Azelby Robert Chief Executive Officer |
0 | $0 | 1,190,462 (Direct) |
View |